Irish venture capital firm Fountain Healthcare Partners has invested €5m in French biotechnology company Inotrem.
US-based parent company Omnimax International sold the business to the Netherlands-based GP
Fund will target companies with revenues of at least €5m, operating in a wide range of innovative sectors
GP intends to support Sicura by boosting its growth both organically and via strategic acquisitions
WFSC joins a group of existing investors that committed to the round in September 2019